Why artificial intelligence will not replace doctors and scientists, but become a tool in their work

An author from Habr AI with nearly 15 years of experience in drug development and diagnostic tool creation offers a sobering view of the role of artificial intelligence in medicine and science. According to the author's assessment, neural networks will not become a universal replacement for doctors and researchers, but can already significantly accelerate their work.

Sobriety After the Hype

The author begins with a simple observation: in biomedicine, almost every major technology is initially perceived as a quick path to defeating diseases. This was already the case with genetic engineering, immuno-oncology, and molecular biology. These fields have indeed brought new treatment and diagnostic methods, but have not eliminated the complexity of the task itself. Even against the backdrop of breakthroughs, there remain diseases that still resist therapy poorly, and the path from discovery to a working drug takes years and requires many checks.

The same thing has happened with artificial intelligence, in the author's view. At the height of the hype, there were statements about the imminent replacement of doctors, automatic drug discovery, and the near-complete elimination of the human factor. But as practical implementation progressed, it became clear that neural networks work best not as independent scientists or clinicians, but as tools within already existing processes. This is not a magic button or digital panacea, but another class of technology that requires quality data, problem formulation, and rigorous verification of results.

Where AI Is Useful

The strongest side of AI in medicine and science is working with large volumes of information, where it is difficult for humans to maintain speed and scale. Algorithms can quickly review publications, find patterns in laboratory data, help with image processing, and highlight suspicious signals for further verification. In pharmaceuticals and diagnostics, this is especially important because research teams constantly face an overabundance of data: papers, molecular profiles, experimental results, images, and clinical observations.

• Initial analysis of scientific publications and patents
• Sorting candidates for preclinical studies
• Analysis of medical images and biomarkers
• Automation of routine documentation and reporting

Practical value appears where AI reduces time on routine work and helps narrow the search field, but does not make the final decision itself. If the system highlighted an unusual pattern, that is not a discovery but a hypothesis. If the model identified an area on an image, that is not a diagnosis but a hint to the doctor. This approach reduces the risk of disappointment: the value of the technology is measured not by loud promises, but by how much it accelerates the cycle of idea verification, increases selection accuracy, and frees specialists for more complex work.

Why Replacement Won't Happen

The main limitation stems from the fact that medicine and biology do not fit well into the logic of pure pattern recognition. A neural network can find statistical coincidences but does not always understand cause-and-effect relationships, which are exactly what clinical decisions and scientific conclusions rest upon. Moreover, models depend on the quality of training data: if the sample is incomplete, biased, or poorly labeled, errors will scale along with automation. In a laboratory or clinic, such an error costs more than in most consumer scenarios, because it affects patient health, money, and time.

There is another reason why replacing a human will not work: a doctor and scientist are responsible not only for calculation but also for interpretation, doubt, ethics, and communication. One must account for the specific patient's history, confounding factors, protocol limitations, contradictory research, and the consequences of an incorrect decision. In science, the formulation of the question, experimental design, and the ability to notice when data does not fit the expected picture are important. AI can help at each of these stages, but so far does not take responsibility and cannot reliably act in conditions of incomplete, noisy, and changing reality.

What This Means

For the market, this is a signal toward a more mature conversation about AI in healthcare. The winners will not be those who promise to completely remove the human from the process, but those who embed models into the work of doctors and researchers as an accelerator for analysis, hypothesis testing, and decision preparation.